Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure

Wiener Klinische Wochenschrift

Volumn 121, Issue 21-22, 2009, Pages 700-706

  Jug, Borut ^a   Šebeštjen, Miran ^a   Šabovič, Mišo ^a   Pohar, Maja ^b   Keber, Irena ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Atrial fibrillation; Heart failure; NT proBNP

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; WARFARIN;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PEPTIDE FRAGMENTS; RISK ASSESSMENT; RISK FACTORS; SLOVENIA;

EID: 77249179795     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1269-5     Document Type: Article

References (32)

1. M Bay V Kirk J Parner C Hassager H Nielsen K Krogsgaard, et al. 2003 NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function Heart 89 150 154 10.1136/heart.89.2.150 1:CAS:528:DC%2BD3sXht1yruro%3D 12527664
2. R Gardner F Ozalp A Murday S Robb T McDonagh 2003 N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 1735 1743 10.1016/j.ehj.2003.07.005 1:CAS:528:DC%2BD3sXns1Krt74%3D 14522568 (Pubitemid 37236862)
3. J Doust E Pietrzak A Dobson P Glasziou 2005 How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure systematic review BMJ 330 625 634 10.1136/bmj.330.7492.625 1:CAS:528:DC%2BD2MXjtlaht74%3D 15774989
4. MT Maeder D Hack H Rickli HPB-L Rocca W Riesen P Ammann 2008 Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure Wien Klin Wochenschr 120 672 678 10.1007/s00508-008-1099-x 1:CAS:528:DC%2BD1MXjvFOktQ%3D%3D 19116708
5. A Rossi M Enriquez-Sarano JC Burnett A Lerman MD Abel JB Seward 2000 Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study J Am Coll Cardiol 35 1256 1262 10.1016/S0735-1097(00)00515-5 1:CAS:528:DC%2BD3cXivVSru7c%3D 10758968 (Pubitemid 30206901)
6. H Silvet Y Young-Xu D Walleigh S Ravid 2003 Brain natriuretic peptide is elevated in outpatients with atrial fibrillation Am J Cardiol 92 1124 1127 10.1016/j.amjcard.2003.07.010 1:CAS:528:DC%2BD3sXosVyltbo%3D 14583372 (Pubitemid 37329544)
7. RJ Shelton AL Clark K Goode AS Rigby JGF Cleland 2006 The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation Eur Heart J 27 2353 2361 10.1093/eurheartj/ehl233 1:CAS:528:DC%2BD28Xht1Sgu7zK 16952921 (Pubitemid 44461764)
8. A Morello D Lloyd-Jones C Chae RR van Kimmenade AC Chen AL Baggish, et al. 2007 Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Am Heart J 153 90 97 10.1016/j.ahj.2006.10.005 1:CAS:528:DC%2BD28XhtlaltLvF 17174644 (Pubitemid 44880879)
9. C Wold Knudsen T Omland P Clopton A Westheim AH Wu P Duc, et al. 2005 Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the Breathing Not Properly multinational study J Am Coll Cardiol 46 838 844 10.1016/j.jacc.2005.05.057 (Pubitemid 41224808)
10. M Rienstra IC Van Gelder MP Van den Berg F Boomsma DJ Van Veldhuisen 2006 Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP Europace 8 482 487 10.1093/europace/eul060 16798760 (Pubitemid 43985484)
11. R D'Agostino 1998 Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 2265 2281 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B 9802183 (Pubitemid 28466823)
12. H Silvet Y Young-Xu D Walleigh S Ravid 2003 Brain natriuretic peptide is elevated in outpatients with atrial fibrillation Am J Cardiol 92 1124 1127 10.1016/j.amjcard.2003.07.010 1:CAS:528:DC%2BD3sXosVyltbo%3D 14583372 (Pubitemid 37329544)
13. PT Ellinor AF Low KK Patton MA Shea C MacRae 2005 Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation J Am Coll Cardiol 45 82 86 10.1016/j.jacc.2004.09.045 1:CAS:528:DC%2BD2MXktlWm 15629379 (Pubitemid 40052031)
14. A Sanfilippo V Abascal M Sheehan LB Oertel P Harrigan RA Hughes, et al. 1990 Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study Circulation 82 792 797 1:STN:280:DyaK3czmslaktw%3D%3D 2144217
15. Y Igarashi K Kashimura Y Makiyama T Sato K Ojima Y Aizawa 2001 Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state Jpn Circ J 65 788 792 10.1253/jcj.65.788 1:CAS:528:DC%2BD3MXmvF2rtrw%3D 11548877 (Pubitemid 32845708)
16. K Doyama M Fukumoto G Takemura M Tanaka T Oda K Hasegawa 1998 Expression and distribution of natriuretic peptide in human right atria J Am Coll Cardiol 32 1832 1838 10.1016/S0735-1097(98)00494-X 1:CAS:528:DyaK1MXhtF2k 9857859 (Pubitemid 29010442)
17. A Tuinenburg B Brundel I van Gelder RH Henning MP Van Den Berg C Driessen, et al. 1999 Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation J Cardiovasc Electrophysiol 10 827 835 10.1111/j.1540-8167.1999.tb00263.x 1:STN:280:DyaK1MzgtlCisQ%3D%3D 10376920 (Pubitemid 29247345)
18. A Luchner T Stevens D Borgeson M Redfield C-M Wei JG Porter, et al. 1998 Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol Heart Circ Physiol 274 H1684 H1689 1:CAS:528:DyaK1cXjsV2jsrs%3D
19. A Luchner F Muders O Dietl E Friedrich F Blumberg AA Protter, et al. 2001 Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction Cardiovascular Res 51 601 607 10.1016/S0008- 6363(01)00316-9 1:CAS:528:DC%2BD3MXltlOit7g%3D (Pubitemid 32718609)
20. S Inoue Y Murakami K Sano H Katoh T Shimada 2000 Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation J Card Fail 6 92 96 10.1016/S1071-9164(00)90010-1 1:CAS:528:DC%2BD3cXlsFSgtL4%3D 10908082
21. H Möllmann M Weber A Elsässer H Nef T Dill J Rixe, et al. 2008 NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation Circ J 72 921 925 10.1253/circj.72.921 18503217 (Pubitemid 351879912)
22. K Tsuchida K Tanabe 2004 Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion J Cardiol 44 1 11 15334879
23. D Shin K Jaekel P Schley A Sause M Müller R Fueth, et al. 2005 Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion Z Kardiol 94 795 800 10.1007/s00392-005-0301-7 1:CAS:528:DC%2BD28XhvVWitL8%3D 16382379 (Pubitemid 43029746)
24. C Vinch J Rashkin G Logsetty DA Tighe JC Hill T Meyer, et al. 2004 Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm Cardiol 102 188 193 10.1159/000081009 1:CAS:528:DC%2BD2cXos1Wks7o%3D (Pubitemid 39370532)
25. B Wozskowsa-Kapton 2004 Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation Am J Cardiol 93 1555 1558 10.1016/j.amjcard.2004.03.013 (Pubitemid 38749221)
26. P Jourdain M Bellorini F Funck Y Fulla N Guillard J Loiret, et al. 2002 Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study Eur J Heart Fail 4 263 267 10.1016/S1388-9842(02) 00004-1 1:CAS:528:DC%2BD38XktVGisro%3D 12034150 (Pubitemid 35190349)
27. A Albage G Keeback J Van der Linden H Berglund 2003 Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure Ann Thorac Surg 75 790 795 10.1016/S0003-4975(02)04543-5 12645695 (Pubitemid 36298342)
28. FM Fruhwald A Fahrleitner N Watzinger S Fruhwald H Dobnig M Schumacher, et al. 1999 Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy Eur Heart J 20 1415 1423 10.1053/euhj.1999. 1633 1:CAS:528:DyaK1MXms1Whtbc%3D 10487802 (Pubitemid 29435708)
29. P Ambrosi C Oddoze G Habib 2002 Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 106 595 601 10.1161/01.CIR.0000033850.92934.3E
30. J Grewal R McKelvie E Lonn P Tait J Carlsson M Gianni, et al. 2008 BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction Eur J Heart Fail 10 252 259 10.1016/j.ejheart.2008.01.017 1:CAS:528: DC%2BD1cXjtVCit7g%3D 18331967 (Pubitemid 351343862)
31. SF Nagueh HA Kopelen MA Quinones 1996 Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation Circulation 94 2138 2145 1:STN:280:DyaK2s%2Flslehtw%3D%3D 8901664
32. WJ Paulus C Tschope JE Sanderson C Rusconi FA Flachskampf FE Rademakers, et al. 2007 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2539 2550 10.1093/eurheartj/ehm037 17428822 (Pubitemid 47614269)